ThromboGenics

ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A

ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A

Bloomberg

ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A

ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A

Bloomberg

Analysis: Maturing Belgian biotechs outshine European peers

Analysis: Maturing Belgian biotechs outshine European peers

Reuters

With FDA panel nod, ThromboGenics closer to first potential drug

With FDA panel nod, ThromboGenics closer to first potential drug

Fierce Biotech

Thrombogenics CEO Discusses Product Pipeline Ahead of Catalyts, FDA Review

Thrombogenics CEO Discusses Product Pipeline Ahead of Catalysts, FDA Review

Yahoo/Reuters

News

ThromboGenics Seeks Cash Deal on Clot Drug to Fund Microplasmin

Bloomberg